{"nctId":"NCT01281475","briefTitle":"A Trial of Levodopa in Angelman Syndrome","startDateStruct":{"date":"2011-01"},"conditions":["Angelman Syndrome"],"count":67,"armGroups":[{"label":"Levodopa","type":"EXPERIMENTAL","interventionNames":["Drug: Levodopa"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo Oral Capsule"]}],"interventions":[{"name":"Levodopa","otherNames":["Sinemet","L-dopa"]},{"name":"Placebo Oral Capsule","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Age between 4 years and 12 years (i.e., before the 13th birthday)\n2. Molecular confirmation of the diagnosis of AS, which may include abnormal methylation studies or UBE3A mutation analyses - only subjects with a molecular diagnosis will be allowed to enroll\n3. Not on LD, CD, or any dopamine agonists in the 2 weeks prior to participation\n\nExclusion Criteria:\n\n1. Co-morbid disorders that may be associated with developmental or cognitive delays\n2. Poorly controlled seizures - An average of more than 2 clinical seizures per month in the 12 months prior to enrollment.\n3. Use of medications that may interact with LD/CD including atypical antipsychotics (aripiprazole, asenapine, iloperidone, olanzapine, paliperidone, risperidone, ziprasidone), monoamine oxidase inhibitors (isocarboxazid, phenelzine, selegiline, tranylcypromine), or phenytoin within the last 14 days, or other investigational interventions within the past 3 months\n4. Presence of cardiovascular disease or instability, respiratory disease, liver disease, peptic ulcer disease, renal impairment, or hematological disorders\n5. Pregnancy","healthyVolunteers":false,"sex":"ALL","minimumAge":"4 Years","maximumAge":"12 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Bayley Cognitive Age Equivalent at 1 Year","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":"7"},{"groupId":"OG001","value":"19","spread":"8"}]}]}]},{"type":"SECONDARY","title":"Presence of Tremors","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":33},"commonTop":["Seizures"]}}}